Home/Filings/4/0001144204-16-079613
4//SEC Filing

ALBANY MOLECULAR RESEARCH INC 4

Accession 0001144204-16-079613

CIK 0001065087operating

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 5:27 PM ET

Size

8.2 KB

Accession

0001144204-16-079613

Insider Transaction Report

Form 4
Period: 2016-02-04
Transactions
  • Award

    Common Stock

    2016-02-04$15.77/sh+2,854$45,0082,854 total
  • Award

    Option to Purchase Common Stock

    2016-02-04$15.77/sh+6,540$103,1366,540 total
    Exercise: $15.77From: 2017-02-04Exp: 2026-02-04Common Stock (6,540 underlying)
Holdings
  • Common Stock

    (indirect: See Footnote)
    2,200,000
Footnotes (1)
  • [F1]These shares are held directly by 3-Gutinver, S.L., a company organized and existing under the laws of Spain. The Reporting Person is the Sole Administrator of 3-Gutinver, S.L. and may be deemed to beneficially hold these securities in such capacity. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for the purposes of Section 16 or any other purpose.

Issuer

ALBANY MOLECULAR RESEARCH INC

CIK 0001065087

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001065087

Filing Metadata

Form type
4
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 5:27 PM ET
Size
8.2 KB